26 related articles for article (PubMed ID: 21308723)
1. Fitting and Cross-Validating Cox Models to Censored Big Data With Missing Values Using Extensions of Partial Least Squares Regression Models.
Bertrand F; Maumy-Bertrand M
Front Big Data; 2021; 4():684794. PubMed ID: 34790895
[TBL] [Abstract][Full Text] [Related]
2. Identification of influential observations in high-dimensional cancer survival data through the rank product test.
Carrasquinha E; Veríssimo A; Lopes MB; Vinga S
BioData Min; 2018; 11():1. PubMed ID: 29456628
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
Islam MA; Kibria MK; Hossen MB; Reza MS; Tasmia SA; Tuly KF; Mosharof MP; Kabir SR; Kabir MH; Mollah MNH
Sci Rep; 2023 Mar; 13(1):4685. PubMed ID: 36949176
[TBL] [Abstract][Full Text] [Related]
4. GradientScanSurv-An exhaustive association test method for gene expression data with censored survival outcome.
Yi M; Zhu R; Stephens RM
PLoS One; 2018; 13(12):e0207590. PubMed ID: 30517129
[TBL] [Abstract][Full Text] [Related]
5. Hyper expression of MTBP may be an adverse signal for the survival of some malignant tumors: A data-based analysis and clinical observation.
Mao Y; Tian M; Pan B; Zhu Q; Li P; Liu H; Liu W; Dai N; Yu L; Tian Y
Medicine (Baltimore); 2018 Aug; 97(35):e12021. PubMed ID: 30170409
[TBL] [Abstract][Full Text] [Related]
6. ALK1Fc Suppresses the Human Prostate Cancer Growth in
Astrologo L; Zoni E; Karkampouna S; Gray PC; Klima I; Grosjean J; Goumans MJ; Hawinkels LJAC; van der Pluijm G; Spahn M; Thalmann GN; Ten Dijke P; Kruithof-de Julio M
Front Cell Dev Biol; 2017; 5():104. PubMed ID: 29259971
[TBL] [Abstract][Full Text] [Related]
7. NOD2 maybe a biomarker for the survival of kidney cancer patients.
Xu D; Zhang S; Zhang S; Liu H; Li P; Yu L; Shang H; Hou Y; Tian Y
Oncotarget; 2017 Nov; 8(60):101489-101499. PubMed ID: 29254180
[TBL] [Abstract][Full Text] [Related]
8. Methylomic predictors demonstrate the role of NF-κB in old-age mortality and are unrelated to the aging-associated epigenetic drift.
Jylhävä J; Kananen L; Raitanen J; Marttila S; Nevalainen T; Hervonen A; Jylhä M; Hurme M
Oncotarget; 2016 Apr; 7(15):19228-41. PubMed ID: 27015559
[TBL] [Abstract][Full Text] [Related]
9. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis.
Aguirre-Gamboa R; Gomez-Rueda H; Martínez-Ledesma E; Martínez-Torteya A; Chacolla-Huaringa R; Rodriguez-Barrientos A; Tamez-Peña JG; Treviño V
PLoS One; 2013; 8(9):e74250. PubMed ID: 24066126
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis by penalized regression and matrix factorization.
Lai Y; Hayashida M; Akutsu T
ScientificWorldJournal; 2013; 2013():632030. PubMed ID: 23737722
[TBL] [Abstract][Full Text] [Related]
11. Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence.
Wang YK; Print CG; Crampin EJ
BMC Genomics; 2013 Feb; 14():102. PubMed ID: 23405961
[TBL] [Abstract][Full Text] [Related]
12. Survival prediction based on compound covariate under Cox proportional hazard models.
Emura T; Chen YH; Chen HY
PLoS One; 2012; 7(10):e47627. PubMed ID: 23112827
[TBL] [Abstract][Full Text] [Related]
13. Analysis of additive risk model with high-dimensional covariates using partial least squares.
Zhao Y; Zhou Y; Zhao M
Stat Med; 2009 Jan; 28(2):181-93. PubMed ID: 18800330
[TBL] [Abstract][Full Text] [Related]
14. Predicting survival from microarray data--a comparative study.
Bøvelstad HM; Nygård S; Størvold HL; Aldrin M; Borgan Ø; Frigessi A; Lingjaerde OC
Bioinformatics; 2007 Aug; 23(16):2080-7. PubMed ID: 17553857
[TBL] [Abstract][Full Text] [Related]
15. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data.
Gui J; Li H
Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556
[TBL] [Abstract][Full Text] [Related]
16. Assessment of survival prediction models based on microarray data.
Schumacher M; Binder H; Gerds T
Bioinformatics; 2007 Jul; 23(14):1768-74. PubMed ID: 17485430
[TBL] [Abstract][Full Text] [Related]
17. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
Segal MR
Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
[TBL] [Abstract][Full Text] [Related]
18. Assessment of evaluation criteria for survival prediction from genomic data.
Bøvelstad HM; Borgan O
Biom J; 2011 Mar; 53(2):202-16. PubMed ID: 21308723
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
